Company Overview: Ambev S.A. is a leading Brazilian beverage company known for its beer and soft drink brands, reporting Q2 2025 revenue of $3.59 billion, a 2.65% increase year-over-year, despite falling short of analyst expectations.
Leadership and Strategy: The company appointed new executives to enhance strategic execution and has increased its dividend to $0.023 per share, reflecting a commitment to shareholder returns while navigating market challenges.
ABEV
$2.565+Infinity%1D
Analyst Views on ABEV
Wall Street analysts forecast ABEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABEV is 2.74 USD with a low forecast of 1.95 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast ABEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABEV is 2.74 USD with a low forecast of 1.95 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
1 Sell
Hold
Current: 2.590
Low
1.95
Averages
2.74
High
4.00
Current: 2.590
Low
1.95
Averages
2.74
High
4.00
Bernstein
Outperform
to
Market Perform
downgrade
$2.88
2025-11-26
Reason
Bernstein
Price Target
$2.88
2025-11-26
downgrade
Outperform
to
Market Perform
Reason
Bernstein downgraded Ambev to Market Perform from Outperform with a $2.88 price target. The firm cites valuation for the downgrade with the shares up 16% year-to-date. Bernstein continues to like Ambev's long-term fundamentals, but believes current expectations "are now overblown." The firm recommends investors take profits and wait for a more attractive entry point.
UBS
Rodrigo Alcantara
Neutral
downgrade
2025-08-20
Reason
UBS
Rodrigo Alcantara
Price Target
2025-08-20
downgrade
Neutral
Reason
UBS analyst Rodrigo Alcantara lowered the firm's price target on Ambev to $2.20 from $2.50 and keeps a Neutral rating on the shares.
HSBC
Carlos Laboy
Buy
to
Hold
downgrade
R$14
2025-08-01
Reason
HSBC
Carlos Laboy
Price Target
R$14
2025-08-01
downgrade
Buy
to
Hold
Reason
HSBC analyst Carlos Laboy downgraded Ambev to Hold from Buy with a R$14 price target.
UBS
Neutral
maintain
2025-06-04
Reason
UBS
Price Target
2025-06-04
maintain
Neutral
Reason
UBS raised the firm's price target on Ambev to $2.70 from $2.60 and keeps a Neutral rating on the shares.
About ABEV
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
